A novel exposure system generating nebulized aerosol of sulfur mustard in comparison to the standard submerse exposure.


Journal

Chemico-biological interactions
ISSN: 1872-7786
Titre abrégé: Chem Biol Interact
Pays: Ireland
ID NLM: 0227276

Informations de publication

Date de publication:
25 Jan 2019
Historique:
received: 09 10 2018
revised: 10 11 2018
accepted: 27 11 2018
pubmed: 7 12 2018
medline: 10 1 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

Inhalation of the chemical warfare agent sulfur mustard (SM) is associated with severe acute and long-term pulmonary dysfunctions and health effects. The still not completely elucidated molecular toxicology and a missing targeted therapy emphasize the need for further research. However, appropriate human data are extremely rare. In vivo animal experiments are often regarded as gold standard in toxicology but may exhibit significant differences compared to the human pulmonary anatomy and physiology. Thus, alternative in vitro exposure methods, adapted to the human in vivo situation by exposing cells at the air-liquid interface (ALI), are complimentary approaches at a cellular level. So far, it is unclear whether the enhanced experimental complexity of ALI exposure, that is potentially biologically more meaningful, is superior to submerged exposures which are typically performed. Aim of our study was the evaluation of an appropriate in vitro exposure system (CULTEX

Identifiants

pubmed: 30502332
pii: S0009-2797(18)31346-2
doi: 10.1016/j.cbi.2018.11.025
pii:
doi:

Substances chimiques

Aerosols 0
Chemical Warfare Agents 0
DNA Adducts 0
Mustard Gas T8KEC9FH9P

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-128

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Amelie Tsoutsoulopoulos (A)

Bundeswehr Institute of Pharmacology and Toxicology, 80937, Munich, Germany.

Markus Siegert (M)

Bundeswehr Institute of Pharmacology and Toxicology, 80937, Munich, Germany; Department of Chemistry, Humboldt-Universität zu Berlin, 12489, Berlin, Germany.

Harald John (H)

Bundeswehr Institute of Pharmacology and Toxicology, 80937, Munich, Germany.

Tabea Zubel (T)

Molecular Toxicology Group, Department of Biology, University of Konstanz, 78457, Konstanz, Germany.

Aswin Mangerich (A)

Molecular Toxicology Group, Department of Biology, University of Konstanz, 78457, Konstanz, Germany.

Annette Schmidt (A)

Bundeswehr Institute of Pharmacology and Toxicology, 80937, Munich, Germany; Universität der Bundeswehr München, Faculty of Human Sciences, Department for Sports Sciences, 85577, Neubiberg, Germany.

Harald Mückter (H)

Walther Straub Institute of Pharmacology and Toxicology, University of Munich, 80336, Munich, Germany.

Thomas Gudermann (T)

Walther Straub Institute of Pharmacology and Toxicology, University of Munich, 80336, Munich, Germany.

Horst Thiermann (H)

Bundeswehr Institute of Pharmacology and Toxicology, 80937, Munich, Germany.

Dirk Steinritz (D)

Bundeswehr Institute of Pharmacology and Toxicology, 80937, Munich, Germany; Walther Straub Institute of Pharmacology and Toxicology, University of Munich, 80336, Munich, Germany.

Tanja Popp (T)

Bundeswehr Institute of Pharmacology and Toxicology, 80937, Munich, Germany; Walther Straub Institute of Pharmacology and Toxicology, University of Munich, 80336, Munich, Germany. Electronic address: tanjapopp@bundeswehr.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH